Last quarter (Q2 2024), Myriad Uranium Corp's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Myriad Uranium Corp's net income was $-4.00M. See Myriad Uranium Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Apr 24	Apr 23	Apr 22	Apr 21	Apr 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 5.70M	$ 2.19M	$ 1.48M	$ 204.38K	$ 276.41K	$ ―
Operating Income	$ -5.70M	$ -2.19M	$ -1.48M	$ -204.38K	$ -276.41K	$ ―
Net Non Operating Interest Income Expense	$ 45.04K	$ 26.09K	$ 8.78K	$ 7.20K	$ -3.22K	$ ―
Other Income Expense	$ ―	$ ―	$ 30.00K	$ 134.06K	$ ―	$ ―
Pretax Income	$ -7.20M	$ -3.68M	$ -1.50M	$ -331.24K	$ -273.19K	$ ―
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -7.20M	$ -3.68M	$ -1.50M	$ -331.24K	$ -273.19K	$ ―
Basic EPS	$ -0.18	$ -0.12	$ -0.07	$ -0.02	$ -0.03	$ -0.03
Diluted EPS	$ -0.18	$ -0.12	$ -0.07	$ -0.02	$ -0.03	$ -0.03
Basic Average Shares	$ 146.08M	$ 30.63M	$ 21.98M	$ 15.18M	$ 9.09M	$ 5.00M
Diluted Average Shares	$ 146.08M	$ 30.63M	$ 21.98M	$ 15.18M	$ 9.09M	$ 5.00M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 5.70M	$ 2.19M	$ 1.48M	$ 204.38K	$ -276.41K	$ ―
Net Income From Continuing And Discontinued Operation	$ -7.20M	$ -3.68M	$ -1.50M	$ -331.24K	$ -273.19K	$ ―
Normalized Income	$ -4.98M	$ -1.19M	$ -1.10M	$ -109.40K	$ -200.79K	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -7.20M	$ -3.68M	$ -1.50M	$ -331.24K	$ -273.19K	$ ―
EBITDA	$ -7.20M	$ -3.68M	$ -1.50M	$ -331.24K	$ -273.19K	$ ―

Currency in USD

Myriad Uranium Corp Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing